Find and Pitch Jounalists, Get Your Story Covered

Tags: enterprise b2b marketplace column ec column ec enterprise

	Profile	Recent Articles on Subject
1	The Conversation Science Alert Science news. Official account. Australia science news	Identifying Chemicals in Our Environment Could Help Medicines Work Better - 19 days ago Will AI revolutionise drug development? Researchers say it depends on how it’s used - 26 days ago
2	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Oxford Drug Design achieves in vivo validation for novel cancer treatment - about 2 months ago Orbit Discovery and Evergreen Theragnostics expand research collaboration - 3 months ago Alleo and Ubiquigent unite to accelerate drug discovery - 5 months ago Alchemab receives funding boost for Parkinson’s research - 9 months ago Disco tunes into new cancer drug targets - about 1 year ago
3	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	PharmaVoice’s Crystal Ball: The industry’s AI future - about 2 months ago 3 closely watched drugs that failed in the clinic - 3 months ago Neuro drugs are still faltering, despite rising investment - 7 months ago Mining clues from a library of brain tissue samples, Cerevance takes a precision approach to CNS disorders - 8 months ago Up-and-comers look for an edge in the bustling ADC field - 8 months ago
4	Meghana Keshavan STAT News Biotech nerd and writer @statnews. biotechwriting	Merck is a new year outlier with its diabetes drug - about 2 months ago
5	<em>The Scientist</em> The Scientist Exploring Life, Inspiring Innovation. scienceinnovation	Leveraging Recombinant Kinases for Drug Discovery Research - 2 months ago
6	<em>The Scientist</em> Staff The Scientist Exploring Life, Inspiring Innovation. scienceinnovation	New Frontiers in Vaccine Development - 3 months ago Curiosity and Compassion Fuel Rare Disease Research - about 1 year ago
7	Brittany Trang STAT News Health care business reporter. PhD. Indie rock fan. health carebusiness reporting	STAT+: Using AI to design small molecule drugs is tough. Here are five companies trying to crack the code - 3 months ago STAT+: AI in drug discovery is ‘nonsense,’ but call Schrödinger ‘AI’ if you want, says CEO - 3 months ago
8	Michael Gibney Pharma Voice Teacher of English. Teacher of politics. Santiago, Chile educationpolitics	As new Alzheimer’s biomarkers come into play, here’s where the money is going - 5 months ago AlphaFold’s Nobel Prize is ‘the dawn of a new era’ in mapping drug development potential - 5 months ago Huntington’s disease R&D is regaining ground after several disappointments - 6 months ago Will the IRA squash new drugs? Those worries are likely exaggerated, studies say. - 6 months ago 23andMe inches closes to cancer immunotherapy, guided by its genetic database - 6 months ago A biotech’s difficult journey to bring a new kind of Parkinson’s drug to patients - 7 months ago Why AlphaFold 3 is stirring up so much buzz in pharma - 10 months ago Now a biopharma powerhouse, Vertex’s R&D bedrock could deliver tomorrow’s blockbusters - 10 months ago A dementia-focused VC digs past anti-amyloid for neuroscience diamonds in the rough - 11 months ago With a rise in animal-human organ transplants, a drugmaker aims for a new standard of care - 11 months ago An ocean of answers in a single cell — how proteomics can lead to better drugs - 12 months ago Big hopes for schizophrenia treatment rely on a deep pipeline of new approaches - 12 months ago A biotech tackles drug discovery with transcription factor know-how - over 1 year ago
9	Jason Mast STAT News Writing about science, medicine. ScienceMedicineBusiness	STAT+: U.K. charities give $36 million to start new drugs for childhood tumors - 6 months ago
10	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	Pharmacy Focus: Alzheimer Drug Pipeline Expands, Promising Therapies in Development - 6 months ago Novel Drugs Targeting Different Pathways Show Promise in Schizophrenia - 11 months ago

Journalists covering drug discovery